VEIL.AI is a spin-off company from FIMM, Institute for Molecular Medicine, Finland (www.helsinki.fi/en/hilife-fimm). FIMM is a research institute under the University of Helsinki and it is the Finnish node of the Nordic EMBL Partnership for Molecular Medicine. VEIL.AI services (anonymization, data synthetization, risk management and regulatory compliance) help healthcare actors to utilize, combine, analyze and share valuable sensitive data more securely, efficiently and with richer quality. The AI solutions from VEIL.AI allow to combine, pseudonymise and anonymise sensitive data from multiple parties in real-time with unmatched scalability. This technology allows the utilisation of synthetic data to gain real world insights for rapid prototyping, feasibility and hypothesis testing with zero privacy risks. The VEIL.AI team has substantial experience in developing solutions and technologies for management of sensitive health data and can deliver high impact expertise for the project, especially to solve the technological challenges related to wide and safe utilization of the sensitive health data. Their pseudonymization protocol CORE is currently in wide use in the Finnish professional biobanking environment. In DECIDER, VEIL.AI provides solutions for secure data management. www.veil.ai/
VEIL.AI Ltd, Finland
Tuomo Pentikäinen manages currently the VEIL.AI company – a spin-out from Institute for Molecular Medicine Finland. He has 20 years experience in building and running research-based start-ups and scale-ups in Finland, Sweden, Switzerland and the USA. Prior to his business career he has worked as a senior researcher and research group leader at VTT – Technical Research Center of Finland, and as a director of an innovation financing programme. His specific competences consist of business, product and go-to-market strategies and risk financing. He holds an M.Sc (Econ) degree from Helsinki School of Economics and Business administration.